Targeting Mediators of Smoking Persistence with Intranasal Insulin
Rapid-acting, non-irritating nasal treatment options for smoking cessation pharmacotherapy are lacking. The halt in development is due, in part, to difficulty in delivering compounds across the blood brain barrier. Recently, in both human and animal models, insulin was shown to be capable of being t...
Saved in:
Main Author: | Ajna Hamidovic (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2017-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intranasal inverted tooth: A rare cause of a persistent rhinosinusitis
by: José Wilson Noleto, et al.
Published: (2013) -
Intranasal delivery of paeoniflorin nanocrystals for brain targeting
by: Chaoyin Wu, et al.
Published: (2020) -
Can Intranasal Insulin and Cholinergic Agonist Improve Post-Covid-19 Cognition Impairment?
by: Amr Ahmed, et al.
Published: (2024) -
High‐dose intranasal insulin in an adaptive dose‐escalation study in healthy human participants
by: Florian Schmitzberger, et al.
Published: (2024) -
Synthesis of an insulin-loaded mucoadhesive nanoparticle designed for intranasal administration: focus on new diffusion media
by: Tahereh Jamshidnejad-Tosaramandani, et al.
Published: (2023)